U.S. Electric Utilities Stock News

Palomar Holdings (PLMR) is back in focus after recent market commentary flagged a tricky mix of weaker commercial pricing, a rotation out of insurance names, and nagging questions around underwriting margins. See our latest analysis for Palomar Holdings. Against that backdrop, Palomar’s share price has still posted a solid year to date share price return. The recent 7 day share price return of 8.2% suggests sentiment is stabilising after earlier volatility, and its multi year total...

Recently, Public Service Enterprise Group’s subsidiaries PSEG Long Island and Public Service Electric & Gas were ranked first and second in the J.D. Power 2025 Electric Utility Business Customer Satisfaction Study for large business customers in the East. This recognition reinforces the group’s long-running efforts to improve service quality and strengthens its reputation with both regulators and commercial clients. We’ll now examine how this top-tier customer satisfaction performance may...

iRobot (IRBT) just hit two major turning points at once: a voluntary Chapter 11 filing and a Nasdaq delisting notice, effectively signaling the endgame for its public equity story. See our latest analysis for iRobot. Those Chapter 11 and delisting headlines basically crystallise what the share price had been hinting at for a while. A 1 year total shareholder return of around minus 91 percent and multi year losses show that momentum has not just faded; it has largely evaporated, as equity...

Duluth Holdings (DLTH) has just posted Q3 2026 results with revenue of $114.9 million and basic EPS of -$0.29, as investors continue to watch how its top line and per share losses evolve. The company has seen quarterly revenue move from $127.1 million in Q3 2025 to $114.9 million in Q3 2026, while basic EPS shifted from -$0.85 to -$0.29 over the same period. This sets the stage for a closer look at how stubborn losses are shaping margins and sentiment. See our full analysis for Duluth...

If you are wondering whether Okta is genuinely a comeback story or just another pricey growth name in cybersecurity, you are not alone. It is exactly the kind of setup where valuation really matters. After a bumpy few years, the stock has climbed to around $90.59, with a 3.2% gain over the last week, 7.9% over the past month, and 14.9% year to date, even though the 5 year return is still down 68.3%. Recent headlines have focused on Okta tightening its focus on identity and access management...

Constellium SE has completed and inaugurated new finishing lines at its Singen plant in Germany, finalizing a €30 million investment with Lotte Infracell to supply high-quality aluminum foilstock for battery applications in Europe. The project not only broadens Constellium’s exposure to the European battery supply chain but also strengthens its ESG profile through on-site solar power generation and enhanced safety infrastructure. We’ll now examine how this Singen battery-foil expansion, with...

If you are wondering whether Regeneron Pharmaceuticals is still worth considering after its big run, or if most of the upside is already reflected in the price, this breakdown outlines where the potential value may be found. The stock has climbed 7.8% over the last week and 7.6% over the last month, reaching about $746.36, while longer-term returns sit at 4.4% year to date and 53.1% over five years. Recent attention has focused on Regeneron's expanding pipeline and its position in high-value...

Main Street Capital (MAIN) has quietly pulled back about 3 % over the past week even as its one year total return sits near 17 %. That gap is where the opportunity gets interesting. See our latest analysis for Main Street Capital. The 7 day share price pullback sits against a modest year to date share price gain and a much stronger one year total shareholder return, suggesting short term nerves but still healthy long term momentum as income focused investors stick with the story. If MAIN has...

Recently, investors learned that ICU Medical’s annualized revenue growth over the last two years has slowed to 2.1%, while analysts now project a 7.7% revenue decline over the next 12 months amid softer demand. At the same time, a steep drop in the company’s free cash flow margin over the past five years points to rising capital needs and increasing financial strain on the business. Next, we’ll examine how concerns over slowing revenue growth could reshape ICU Medical’s previously more...

Innodata (INOD) is leaning hard into its new role as a generative AI data engineering partner, and the early payoff is showing up in both its expanding tech relationships and improving profitability metrics. See our latest analysis for Innodata. The buzz around Innodata’s new generative AI and federal defense work comes against a choppier backdrop, with a 1 year total shareholder return of 35.08 percent but a weaker recent share price trend that suggests momentum is cooling after a powerful...

Edwards Lifesciences (EW) is back in the spotlight after upbeat commentary around its latest earnings call, stronger sales growth, and raised guidance, a combination that often reshapes how investors think about long term upside and risk. See our latest analysis for Edwards Lifesciences. At around $85.32, Edwards Lifesciences has enjoyed a 90 day share price return of 13.46 percent and a 1 year total shareholder return of 15.11 percent, suggesting momentum is building as investors warm to its...

Phathom Pharmaceuticals stock reacts to upbeat earnings and new trial progress Phathom Pharmaceuticals (PHAT) grabbed investor attention after a bullish new analyst rating landed alongside quarterly results that beat forecasts, a raised 2025 revenue outlook, and fresh clinical progress for VOQUEZNA. See our latest analysis for Phathom Pharmaceuticals. Those upbeat earnings, stronger VOQUEZNA narrative, and the new Strong Buy call appear to be feeding into a powerful trend, with a roughly 108...

Antero Resources (AR) has been drifting lower over the past week, even though its underlying business continues to grow revenue and earnings at a healthy clip. That disconnect is what makes the stock interesting right now. See our latest analysis for Antero Resources. The recent pullback, including a 1 week share price return of negative 11.03 percent and a year to date share price return of negative 6.58 percent at 33.23 dollars, contrasts with a resilient 1 year total shareholder return of...

Morgan Stanley recently downgraded Atmos Energy to an Equal-Weight rating even as the company posted strong fiscal 2025 earnings per diluted share of US$7.46 and extended its decades-long streak of dividend increases. Atmos also outlined higher capital spending and constructive 2026 earnings guidance, underscoring how regulatory support and infrastructure investment are shaping its long-term profile despite mixed analyst sentiment. We’ll now examine how Atmos’s robust EPS growth and higher...

The St. Joe Company recently began developing a Publix Super Market at its Watersound West Bay Center in Panama City Beach, planning a 50,000-square-foot store with pharmacy, deli, bakery and adjacent liquor store alongside additional leasable retail space. This project deepens St. Joe’s commercial leasing base while tying its retail footprint directly to the growing Latitude Margaritaville Watersound and Ward Creek residential communities along the State Road 79 corridor. We’ll now look at...

Inter Parfums’ Chairman and CEO Jean Madar recently bought 25,000 company shares, according to a regulatory filing made on 15 December 2025. This sizeable insider purchase highlights management’s willingness to commit personal capital, which many investors view as a meaningful signal of confidence. We’ll now explore how this insider buying supports Inter Parfums’ asset-light, digitally focused growth narrative and what it might mean for investors. Rare earth metals are the new gold rush...

Wondering if Teradata is quietly turning into a value opportunity, or if the market is rightly cautious at around $29.68? This breakdown will help you decide whether the current price really makes sense. The stock has slipped about 5.5% over the last week but is still up roughly 9.0% over the past month, leaving shares down 3.2% year to date and about 9.5% lower over the last year. This pattern hints at shifting sentiment rather than a clear trend. Recently, the market has been reacting to...

Peraton’s new strategic partnership with Zscaler (ZS) focuses on integrating hybrid multicloud infrastructure with cloud native Zero Trust security, targeting mission critical government and enterprise environments. See our latest analysis for Zscaler. For Zscaler, the Peraton deal lands during a choppy spell, with a 30 day share price return of minus 22.26 percent but a still solid year to date share price return of 28.14 percent and a resilient 3 year total shareholder return of 105.02...

Hexcel (HXL) has quietly outperformed many industrial peers this year, with the stock up about 17% year to date and roughly 15% over the past year, as investors revisit aerospace demand. See our latest analysis for Hexcel. At around $72.31 per share, Hexcel has given investors a solid 17.01% year to date share price return, and its 58.24% five year total shareholder return suggests momentum has been steadily building as confidence in aerospace and defense demand improves. If this aerospace...

Willdan Group (WLDN) is back on investors radar after its E3 subsidiary released an independent study for Amazon on how utilities should price and manage surging data center driven electric load. See our latest analysis for Willdan Group. That Amazon backed study is landing at a time when Willdan’s 1 month share price return of 8.2 percent builds on a powerful year to date run of 175.4 percent. Its 3 year total shareholder return of 478.8 percent underlines how long term momentum has steadily...

Liberty Energy (LBRT) has slipped roughly 6% in the past day and 9% over the past week, even after a strong past 3 months. This naturally raises questions about what the market is pricing in now. See our latest analysis for Liberty Energy. Zooming out, that sharp 1 week and 1 day pullback comes after a powerful 90 day share price return of about 65%, while the 1 year total shareholder return is only slightly negative. This suggests momentum is cooling but not broken. If Liberty’s recent...

Kodiak Sciences Inc. recently filed and commenced an underwritten public offering of 6,000,000 shares of its common stock, with underwriters granted a 30-day option to purchase up to an additional 900,000 shares, subject to market and other conditions. This sizeable follow-on equity raise is important for investors because it directly affects Kodiak’s funding profile while introducing the prospect of meaningful shareholder dilution. Next, we’ll examine how this sizable follow-on equity raise...

Hims & Hers Health has expanded into Canada through its acquisition of Livewell, a local digital health platform focused on weight loss, and is building a country-first leadership and medical team to offer more accessible, personalized care. This move positions the company to launch a comprehensive Canadian weight loss program as generic semaglutide first becomes available, potentially broadening its reach in a large, underserved obesity market. We’ll now examine how entering Canada’s weight...

Wondering if LKQ is a quietly mispriced opportunity in the auto parts world, or a value trap hiding in plain sight? You are in the right place if you care about what you are actually paying for future cash flows. The stock has been choppy, with a 6.2% gain over the last week but still down 2.1% over 30 days, and notably 17.4% lower year to date and 15.5% over the past year, highlighting a long stretch of underperformance. Recent headlines have focused on LKQ's ongoing integration efforts...